Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 5, 2001, Pages 641-651

  Goldstein, Ellie J C ^a,b   Citron, Diane M ^a   Merriam, C Vreni ^a   Warren, Yumi A ^a   Tyrrell, Kerin ^a   Fernandez, Helen ^a  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTETAN; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERTAPENEM; LEVOFLOXACIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BACTEROIDES; BACTEROIDES TECTUM; BERGEYELLA ZOOHELCUM; BITE WOUND; CAMPYLOBACTER; CAMPYLOBACTER GRACILIS; CAMPYLOBACTER RECTUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; CORYNEBACTERIUM; DILUTION; DRUG CONCENTRATION; DRUG POTENCY; EIKENELLA CORRODENS; ENTEROCOCCUS FAECALIS; FUSOBACTERIUM; HUMAN; IN VITRO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NONHUMAN; PASTEURELLA; PASTEURELLA CANIS; PASTEURELLA DAGMATIS; PASTEURELLA MULTOCIDA; PATHOGENICITY; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; SKIN; SOFT TISSUE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; WOUND INFECTION;

EID: 0035179533     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.5.641     Document Type: Article

References (19)

1. Bite wounds and infection
2. The bacteriology and management of dog and cat bite wound infections presenting to Emergency Departments
3. New horizons in the bacteriology, antimicrobial susceptibility and therapy of animal bite wounds
4. In vitro activity of MK-0826 compared to imipenem, ceftriaxone, and metronidazole against anaerobic bacteria isolated from intra-abdominal infections
5. In-vitro anti-microbial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests
6. In vitro activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-748,345)
7. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens
8. In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum β-lactamase- and extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates
9. Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates
10. In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria
11. Activity of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections
12. Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans
13. Growth characteristics and a novel method for identification (the Wee Tab system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans
14. Evaluation of RapID CB Plus System for identification of Corynebacterium species and other gram-positive rods
15. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella langaa